Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DR26FDJC0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,125
Award facts
- Contract value 100% obligated
- $5,124.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $5,124.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. The award, issued on November 3, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 25, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies the product to support Department of Defense medical supply requirements at the performance location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, awarded on November 13, 2025, carries a $500 million ceiling value and extends through December 31, 2036, positioning the contractor as a critical regional pharmaceutical supplier within the DLA's broader $30.3 billion PPV-G GEN V acquisition strategy. This structure enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, biologics, and medical consumables to support military healthcare facility operations globally, with EXPAREL representing a specialty surgical anesthetic product within the company's diverse pharmaceutical portfolio.
Quick answers
Who was awarded contract SPE2DR26FDJC0?
SPE2DR26FDJC0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FDJC0 worth?
The government has obligated $5,125 on SPE2DR26FDJC0.
Is contract SPE2DR26FDJC0 an order under another contract?
Yes. SPE2DR26FDJC0 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJC0 competed?
The extent of competition for SPE2DR26FDJC0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award